Gynecologic Oncology

If you’ve been diagnosed with a gynecologic cancer, it’s important to be evaluated by cancer experts before beginning treatment. We can help.

Our team of gynecologic oncology specialists makes us one of the best cancer centers in the nation. They design and conduct clinical trials and translational research, as well as contribute to publications on the surgical and medical management of gynecologic tumors. In addition, several team members are included among the nation’s "Best Doctors" and "Who’s Who in Medicine."

Symptoms of Gynecologic Cancer

The symptoms of gynecologic cancers are not the same for everyone and vary by cancer type, according to the Centers for Disease Control and Prevention. However, symptoms to watch out for include:

  • Abnormal vaginal bleeding or discharge - common in all gynecologic cancers except vulvar cancer
  • Feeling full quickly, bloating, difficulty eating, abdominal pain or back pain - common for ovarian cancer
  • Pelvic pain or pressure - common in ovarian or uterine
  • Frequency or urgency with urination and/or constipation - common in for ovarian or vaginal cancers
  • Itching, burning, pain or tenderness of the vulva or changes in the vulva color or skin including rash, sores or warts - found in vulvar cancer

Evaluation and Diagnosis

Each patient receives personal attention from the Gynecologic Oncology Multidisciplinary Team. During your initial visit, a physician will review your medical records and medical history, x-rays and pathology slides. The team meets regularly to discuss patient care issues and refine individual patient treatment plans.

Patients who benefit most from a consultation with our Gynecology Oncology Multidisciplinary Team include those with:

  • Newly diagnosed gynecologic cancers such as cervical cancer, fallopian tube cancer, gestational trophoblastic disease, ovarian cancer, uterine (endometrial) cancer, vaginal cancer and vulvar cancer needing surgery, radiation and/or chemotherapy
  • Signs suspicious for a gynecologic malignancy such as a complex pelvic mass, malignant ascites and/or elevated CA-125
  • Vulvar, vaginal or cervical lesions suspicious for malignancy on pelvic exam
  • Early cervical cancer interested in fertility-sparing surgery
  • Pelvic masses and endometrial cancer interested in minimally invasive surgery
  • Recurrent gynecologic cancers being considered for surgery, radiation or chemotherapy
  • An interest in clinical trial participation
  • Complicated pre-invasive disease of the lower genital tract
  • Any gynecologic cancer who specifically requests being seen by the multidisciplinary team at Karmanos to initiate treatment or for a second opinion
  • A personal and/or family history suggestive of hereditary gynecologic cancer

Innovative, Individualized Care

The team uses the latest technologies, including the da Vinci® Xi™ Surgical System, cryotherapy and immunotherapy, to achieve optimum success for our patients. Here's what patients can expect from our Gynecologic Oncology Multidisciplinary Team:

  • A passionate, caring, expert team, giving you the best chance of success.
  • A collaborative approach that considers all available treatment options, including clinical trials, for your specific type of cancer.
  • A carefully constructed treatment plan designed to achieve the best possible outcome.
  • Respectful, compassionate care that is responsive to your emotional needs and lifestyle.
  • Proactive, timely communication with you and your loved ones, and your personal physician.

Appointment Information

Request an Appointment Online Request an Appointment By Phone

The Latest From Karmanos Cancer Institute

News

Radhika Gogoi, M.D., receives Geri Fournier Ovarian Cancer Research Grant

Karmanos is pleased to congratulate Radhika Gogoi, M.D., Ph.D. , member of the Gynecologic Oncology Multidisciplinary Team at Karmanos for securin...

Read More

FDA approval granted for new breast imaging tool developed in Detroit

SoftVue™ 3D Whole Breast Ultrasound Tomography System developed by Karmanos Cancer Institute spinoff Delphinus Medical Technologies, LLC Karmanos ...

Read More

Karmanos Cancer Institute receives 2021 Prostate Cancer Foundation Challenge Award

Karmanos is pleased to announce that it has received a Movember – Prostate Cancer Foundation PCF Challenge Award totaling $1 million. PCF Challeng...

Read More
News

ACS CAN Michigan Candid Connection, August 2021 — April Brown

Listen Now

Dr. Al Hallak on alcohol and cancer with WJR

Listen Now

ACS CAN MI CANdid Connection, July 2021 — Anthony Shields, M.D.

Listen Now